Simultaneous determination of terbinafine (Lamisil) and five metabolites in human plasma and urine by high-performance liquid chromatography using on-line solid-phase extraction
Authors:
- J. DenouëlJDJ. Denouël
- M. RoyMRM. Roy
- L. Le SauxLSL. Le Saux
- P. SchaubPSP. Schaub
- 1 February 1995
- journal article
- clinical trial
- Published by Elsevier in Journal of Chromatography B: Biomedical Sciences and Applications
- Vol. 664 (2) , 347-355
Abstract
No abstract availableKeywords
This publication has 6 references indexed in Scilit:
- Levels of terbinafine in plasma, stratum corneum, dermis/epidermis (without stratum corneum), sebum, hair and nails during and after 250 mg terbinafine orally once per day for four weeks.Acta Dermato-Venereologica, 1993
- Terbinafine levels in serum, stratum corneum, dermis-epidermis (without stratum corneum), hair, sebum and eccrine sweat.Acta Dermato-Venereologica, 1991
- Nail matrix kinetics of oral terbinafine in onychomycosis and normal nailsJournal of Dermatological Treatment, 1990
- Clinical pharmacokinetics of terbinafine (Lamisil)Clinical and Experimental Dermatology, 1989
- Validation of assay methodology used in pharmacokinetic studiesJournal of Pharmacological Methods, 1987
- Allylamine Derivatives: New Class of Synthetic Antifungal Agents Inhibiting Fungal Squalene EpoxidaseScience, 1984